Request Samples

For US Healthcare Professionals Only
Prescribing Information

For US Healthcare Professionals Only
Prescribing Information

It’s time to try VEVYE®!

VEVYE® (cyclosporine ophthalmic solution) 0.1% is the first and only
water-free cyclosporine dissolved in a semifluorinated alkane approved to
treat both the signs and symptoms of dry eye disease.1-3

Thank you for your interest in VEVYE. Complete the form below to be included
with those who will be among the first to try VEVYE.

Physician Information

Physician First Name*

Physician Last Name*

Licensed State*

Email Address*

Facility Information

Facility Name*

Address

Street*

Apt/Suite

City*

Zipcode*

*Required field.

I authorize Harrow, Inc., to send me emails regarding VEVYE and other informational materials. I understand that I may revoke this authorization and choose not to receive information from Harrow by clicking the “unsubscribe” link provided in emails I receive from Harrow. I have read and understand Harrow's Privacy Notice.

References: 1. Vevye (cyclosporine ophthalmic solution) 0.1% [package insert]. Harrow IP, LLC; 2023. 2. Restasis (cyclosporine ophthalmic emulsion) 0.06% [package insert]. Allergan, LLC; 2023. 3. Cequa (cyclosporine ophthalmic solution) .09% [package insert]. Sun Ophthalmics, LLC; 2023.

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Potential for Eye Injury and Contamination – To avoid the potential for eye injury and/or contamination, patients should not touch the bottle tip to the eye or other surfaces.

Use with Contact Lenses – VEVYE® should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following the administration of VEVYE®.

Adverse Reactions

In clinical trials with 738 subjects receiving at least 1 dose of VEVYE®, the most common adverse reactions were instillation site reactions (8%) and temporary decreases in visual acuity (3%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call
1-800-FDA-1088.

For additional information about VEVYE®, please see the Full Prescribing Information.

It’s time to try VEVYE®!

Physician Information

Facility Information

Address

Thank YOU for submitting your request!

IMPORTANT SAFETY INFORMATION